US2005191724A1PendingUtilityA1
Nematode-extracted serine protease inhibitors and anticoagulant proteins
Assignee: CORVAS INTERNATIONAL INC A DELPriority: Oct 18, 1994Filed: Mar 29, 2005Published: Sep 1, 2005
Est. expiryOct 18, 2014(expired)· nominal 20-yr term from priority
Inventors:George P. VlasukPatrick StanssensJoris Hilda Lieven MessensMarc Josef LauwereysYves Rene LarocheLaurent JespersYannick GansemansMatthew MoylePeter W. Bergum
A61P 7/02A61P 43/00C07K 14/811Y10S530/829A61K 38/55C12P 21/02
60
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Proteins which have activity as anticoagulants and/or serine protease inhibitors and have at least one NAP domain and are described. Certain of these proteins have factor Xa inhibitory activity and others have activity as inhibitors of factor VIIa/TF. These proteins can be isolated from natural sources as nematodes, chemically synthesized or made by recombinant methods using various DNA expression systems.
Claims
exact text as granted — not AI-modified1 - 269 . (canceled)
270 . A pharmaceutical composition comprising:
(a) a polypeptide having the amino acid sequence LysAlaThrMetGlnCysGlyGluAsnGluLysTyrAspSerCysGlySerLysGluCysAspLys LysCysLysTyrAspGlyValGluGluGluAspAspGluGluProAsnValProCysLeuValArg ValCysHisGlnAspCysValCysGluGluGlyPheTyrArgAsnLysAspAspLysCysValSer AlaGluAspCysGluLeuAspAsnMetAspPheIleTyrProGlyThrArgAsnPro (rNAPc2/Pro); and (b) a pharmaceutically acceptable carrier.
271 . A method for producing a polypeptide comprising the amino acid sequence of rNAPc2, the method comprising
(a) providing a cell encoding a polypeptide comprising the amino acid sequence of rNAPc2; (b) culturing the cell under conditions suitable for the production of the polypeptide comprising the amino acid sequence of rNAPc2; and (c) purifying the polypeptide from the cell culture supernatant.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.